NCT06466330View on ClinicalTrials.gov

Efficacy of Microparticle Geniculate Artery Embolization in Total Knee Prosthesis Patients With Pain Resistant to Medical Treatment. A Prospective Randomized Controlled Trial

NARecruitingINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

March 10, 2025

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2027

Conditions
Knee Pain ChronicKnee Pain Swelling
Interventions
DEVICE

microparticles

inert microparticles

PROCEDURE

embolization

Injection of inert microparticles in neovessels using a microcatheter

PROCEDURE

sham embolization

injection of saline solution

Trial Locations (11)

Unknown

NOT_YET_RECRUITING

Centre Hospitalier Henri Mondor, Créteil

RECRUITING

Centre Hospitalier Dijon, Dijon

RECRUITING

Centre Hospitalier Universitaire de Grenoble, Grenoble

NOT_YET_RECRUITING

Centre Hospitalier Saint-Philibert, Lomme

NOT_YET_RECRUITING

Hôpital Saint Philibert, Lomme

NOT_YET_RECRUITING

CHU Marseille, Marseille

RECRUITING

Centre Hospitalier Universitaire de Nice, Nice

NOT_YET_RECRUITING

Centre Hospitalier de Nîmes, Nîmes

NOT_YET_RECRUITING

Hôpital Lariboisière, Paris

NOT_YET_RECRUITING

Hôpital Saint-Antoine, Paris

NOT_YET_RECRUITING

Hospices Civils de Strasbourg, Strasbourg

Sponsors

Collaborators (1)

Euraxi Pharma
All Listed Sponsors
collaborator

Centre Hospitalier Universitaire de Nice

OTHER

collaborator

Euraxi Pharma

INDUSTRY

lead

Societe Francaise de Rhumatologie

OTHER

NCT06466330 - Efficacy of Microparticle Geniculate Artery Embolization in Total Knee Prosthesis Patients With Pain Resistant to Medical Treatment. A Prospective Randomized Controlled Trial | Biotech Hunter | Biotech Hunter